Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circ Heart Fail. 2016 09; 9(9).

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Cardiotonic Agents
Defibrillators, Implantable
Diuretics
Double-Blind Method
Drug Combinations
Drug Therapy, Combination
Electric Countershock
Enalapril
Heart Failure
Humans
Myocardial Revascularization
Proportional Hazards Models
Prospective Studies
Tetrazoles
Time Factors
Treatment Outcome
Valsartan

authors with profiles

Michael R. Zile